In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From MeMed

Minute Insight: MeMed Adds Whole Blood To Indication For Viral/Bacterial Infection Test

Expanded FDA-cleared labeling will allow labs to test whole blood samples, making the technology available to a wider range of health care facilities.

Infectious Diseases In Vitro Diagnostics

Finding A Way To Bring Graphene To Diagnostics

UK-based Paragraf is working on a range of diagnostic sensors built using graphene, allowing for faster, more sensitive testing products.

Financing Innovation

Paragraf Is Finding A Way To Bring Graphene To Diagnostics

The UK-based company is creating a range of diagnostic sensors built using graphene, allowing for faster, more sensitive testing products.

Financing Innovation

MeMed Secures $93M Financing To Commercialize Diagnostics Platform

The company will use the money to fund its US commercialization strategy and continue to develop its host response-based product pipeline.

Diagnostics Financing
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
UsernamePublicRestriction

Register